About
I am dedicated to delivering holistic psychiatric care, seamlessly integrating biological, psychological, social, and behavioural approaches to promote each individual’s journey toward recovery.
I bring over two decades of experience in both NHS and private practice. I specialise in neuropsychiatry and brain injury rehabilitation, conducting in depth assessments and crafting bespoke treatment plans that may incorporate EMDR, advanced psychopharmacology, and evidence based psychotherapy.
My expertise spans a broad spectrum of conditions including ADHD, OCD, PTSD, depression, anxiety, insomnia, phobias, and trauma related disorders, while also focusing on adolescent and early adult mental health to address emerging challenges in mood, behaviour, and the transition to adulthood.
I pride myself on a compassionate, patient centred approach that empowers individuals and their families, fostering resilience and sustainable wellbeing.
Position at Priory
I have been working with Priory since 2016, providing specialist neuropsychiatric and general psychiatric services.
Training
- Doctorate of Medicine (DM), University of Southampton, UK, 2020
- Member of the Royal College of Psychiatrists (MRCPsych), Royal College of Psychiatrists, London, UK, 2012
- Certificate of clinical psychopharmacology, British Association for Psychopharmacology, UK, 2017
- Certificate of non clinical/preclinical psychopharmacology, British Association for Psychopharmacology, UK, 2014
- Certificate of completion of training (CCT), General Medical Council (GMC), UK, 2016
- Bachelor of medicine and surgery (MBBCh), University of Mansoura, Egypt, 2002
Research interests
- Neuropsychiatry and affective disorders
- Sexual function and dysfunction in anxiety disorders
- Biomarkers and inflammatory markers (for example, cortisol) in anxiety and mood disorders
- Treatment outcomes in epilepsy related aggression
- Frameworks for routine outcome measurement in neuropsychiatry
Links to clinical articles/research papers:
I have authored 20 peer reviewed articles, which together have been cited over 350 times (https://the-psychiatrist.co.uk/about-the-psychiatrist) reflecting the impact of my work on clinical practice and patient outcomes.
From these, patients often find the following studies most directly relevant and accessible:
- Effects of celecoxib augmentation on anxiety symptoms - An exploratory clinical trial demonstrating how anti inflammatory treatment can alleviate anxiety, offering hope for novel, tolerable approaches to chronic worry disorders
- Sexual function outcomes in anxiety disorder treatments - A prospective study tracking men and women through standard therapies, providing clear insights into expected changes in intimate health during recover
- Management of aggression in epilepsy - Practical guidance on reducing behavioural disturbances in people living with epilepsy, emphasising safety and quality of life
Languages
- English
- Arabic